CIK 0001759425
- Large accelerated filer
Mirum Pharmaceuticals, Inc.
Sign in to watch- Ticker
- MIRM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831281555
- Phone
- +1 650-667-4085
- Business address
- 989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
- 4 Grant or award Chief Scientific Officer acquired 595 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 861 shares (grant or award)
- 4 Grant or award Chief Development Officer acquired 822 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 1,275 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 1,371 shares (grant or award)
- 4 Grant or award President and CEO acquired 1,371 shares (grant or award)
- 4 Exercise or conversion Chief Medical Officer acquired 25,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Medical Officer bought 4,500 shares at an average $11.01 ($49,558)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 15 of 18 · 356 filings